{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:16:27Z","timestamp":1777655787083,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11926-019-0841-x","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T07:16:20Z","timestamp":1562138180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis"],"prefix":"10.1007","volume":"21","author":[{"given":"Marie-Pier","family":"T\u00e9treault","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kahrilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"841_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002. \n                      https:\/\/doi.org\/10.1038\/nrdp.2015.2\n                      \n                    .","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"841_CR2","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202\u20135.","journal-title":"J Rheumatol"},{"issue":"3","key":"841_CR3","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","volume":"36","author":"SK Ntoumazios","year":"2006","unstructured":"Ntoumazios SK, Voulgari PV, Potsis K, Koutis E, Tsifetaki N, Assimakopoulos DA. Esophageal involvement in scleroderma: gastroesophageal reflux, the common problem. Semin Arthritis Rheum. 2006;36(3):173\u201381. \n                      https:\/\/doi.org\/10.1016\/j.semarthrit.2006.08.002\n                      \n                    .","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"841_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11926-014-0475-y","volume":"17","author":"DA Carlson","year":"2015","unstructured":"Carlson DA, Hinchcliff M, Pandolfino JE. Advances in the evaluation and management of esophageal disease of systemic sclerosis. Curr Rheumatol Rep. 2015;17(1):475. \n                      https:\/\/doi.org\/10.1007\/s11926-014-0475-y\n                      \n                    .","journal-title":"Curr Rheumatol Rep"},{"issue":"12","key":"841_CR5","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/gut.2005.086074","volume":"55","author":"CG Roberts","year":"2006","unstructured":"Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut. 2006;55(12):1697\u2013703. \n                      https:\/\/doi.org\/10.1136\/gut.2005.086074\n                      \n                    .","journal-title":"Gut."},{"issue":"12","key":"841_CR6","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1002\/1529-0131(199712)40:12<2252::AID-ART21>3.0.CO;2-W","volume":"40","author":"G Bassotti","year":"1997","unstructured":"Bassotti G, Battaglia E, Debernardi V, Germani U, Quiriconi F, Dughera L, et al. Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum. 1997;40(12):2252\u20139. \n                      https:\/\/doi.org\/10.1002\/1529-0131(199712)40:12<2252::AID-ART21>3.0.CO;2-W\n                      \n                    .","journal-title":"Arthritis Rheum"},{"issue":"8","key":"841_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/BF01071951","volume":"21","author":"AL Hurwitz","year":"1976","unstructured":"Hurwitz AL, Duranceau A, Postlethwait RW. Esophageal dysfunction and Raynaud\u2019s phenomenon in patients with scleroderma. Am J Dig Dis. 1976;21(8):601\u20136.","journal-title":"Am J Dig Dis"},{"issue":"3","key":"841_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1572-0241.1998.00341.x","volume":"93","author":"G Lock","year":"1998","unstructured":"Lock G, Pfeifer M, Straub RH, Zeuner M, Lang B, Scholmerich J, et al. Association of esophageal dysfunction and pulmonary function impairment in systemic sclerosis. Am J Gastroenterol. 1998;93(3):341\u20135. \n                      https:\/\/doi.org\/10.1111\/j.1572-0241.1998.00341.x\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"841_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L","volume":"45","author":"I Marie","year":"2001","unstructured":"Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF, et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum. 2001;45(4):346\u201354. \n                      https:\/\/doi.org\/10.1002\/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L\n                      \n                    .","journal-title":"Arthritis Rheum"},{"issue":"6","key":"841_CR10","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/rheumatology\/kes429","volume":"52","author":"E Savarino","year":"2013","unstructured":"Savarino E, Mei F, Parodi A, Ghio M, Furnari M, Gentile A, et al. Gastrointestinal motility disorder assessment in systemic sclerosis. Rheumatology (Oxford). 2013;52(6):1095\u2013100. \n                      https:\/\/doi.org\/10.1093\/rheumatology\/kes429\n                      \n                    .","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"841_CR11","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/BOR.0000000000000325","volume":"28","author":"MY Choi","year":"2016","unstructured":"Choi MY, Fritzler MJ. Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis. Curr Opin Rheumatol. 2016;28(6):586\u201394. \n                      https:\/\/doi.org\/10.1097\/BOR.0000000000000325\n                      \n                    .","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"841_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","volume":"7","author":"WJ van Venrooij","year":"2011","unstructured":"van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol. 2011;7(7):391\u20138. \n                      https:\/\/doi.org\/10.1038\/nrrheum.2011.76\n                      \n                    .","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"841_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jbspin.2017.11.006","volume":"85","author":"G Laustriat","year":"2018","unstructured":"Laustriat G, Ruyssen-Witrand A, Constantin A, Barnetche T, Adoue D, Cantagrel A, et al. Anti-citrullinated peptides antibodies in systemic sclerosis: meta-analysis of frequency and meaning. Joint Bone Spine. 2018;85(2):147\u201353. \n                      https:\/\/doi.org\/10.1016\/j.jbspin.2017.11.006\n                      \n                    .","journal-title":"Joint Bone Spine"},{"issue":"2","key":"841_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.2214\/ajr.161.2.8333359","volume":"161","author":"M Bhalla","year":"1993","unstructured":"Bhalla M, Silver RM, Shepard JA, McLoud TC. Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy. AJR Am J Roentgenol. 1993;161(2):269\u201372. \n                      https:\/\/doi.org\/10.2214\/ajr.161.2.8333359\n                      \n                    .","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"841_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/RHU.0b013e318261176f","volume":"18","author":"S Patiwetwitoon","year":"2012","unstructured":"Patiwetwitoon S, Wangkaew S, Euathrongchit J, Kasitanon N, Louthrenoo W. High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis. J Clin Rheumatol. 2012;18(5):229\u201333. \n                      https:\/\/doi.org\/10.1097\/RHU.0b013e318261176f\n                      \n                    .","journal-title":"J Clin Rheumatol"},{"issue":"945","key":"841_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1259\/bjr\/17000205","volume":"79","author":"EH Pitrez","year":"2006","unstructured":"Pitrez EH, Bredemeier M, Xavier RM, Capobianco KG, Restelli VG, Vieira MV, et al. Oesophageal dysmotility in systemic sclerosis: comparison of HRCT and scintigraphy. Br J Radiol. 2006;79(945):719\u201324. \n                      https:\/\/doi.org\/10.1259\/bjr\/17000205\n                      \n                    .","journal-title":"Br J Radiol"},{"issue":"9","key":"841_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1136\/ard.2007.081612","volume":"67","author":"MC Vonk","year":"2008","unstructured":"Vonk MC, van Die CE, Snoeren MM, Bhansing KJ, van Riel PL, Fransen J, et al. Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma. Ann Rheum Dis. 2008;67(9):1317\u201321. \n                      https:\/\/doi.org\/10.1136\/ard.2007.081612\n                      \n                    .","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"841_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.semarthrit.2010.03.002","volume":"40","author":"RB Christmann","year":"2010","unstructured":"Christmann RB, Wells AU, Capelozzi VL, Silver RM. Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence. Semin Arthritis Rheum. 2010;40(3):241\u20139. \n                      https:\/\/doi.org\/10.1016\/j.semarthrit.2010.03.002\n                      \n                    .","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"841_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1620\/tjem.237.345","volume":"237","author":"D Takekoshi","year":"2015","unstructured":"\u2022 Takekoshi D, Arami S, Sheppard TJ, Cole-Saffold P, Michel JC, Kondos GT, et al. Computed tomography of the esophagus in scleroderma and lung disease. Tohoku J Exp Med. 2015;237(4):345\u201352. \n                      https:\/\/doi.org\/10.1620\/tjem.237.345\n                      \n                     . This retrospective study analysis of the esophageal diameter of 121 SSc patients with ILD and 48 SSc without ILD along with 121 pulmonary clinic patients and 110 normal subjects demonstrated that SSc patients with ILD had greater diameters than those from SSc patients without ILD or from pulmonary clinic patients.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"841_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","volume":"46","author":"C Richardson","year":"2016","unstructured":"\u2022 Richardson C, Agrawal R, Lee J, Almagor O, Nelson R, Varga J, et al. Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study. Semin Arthritis Rheum. 2016;46(1):109\u201314. \n                      https:\/\/doi.org\/10.1016\/j.semarthrit.2016.02.004\n                      \n                    . This cross-sectional study analyzed the esophageal diameter of 270 SSc subjects. The study demonstrated an association between an increasing diameter in SSc patients and more severe radiographic ILD and lower PFT parameters.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"841_CR21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s40674-014-0005-0","volume":"1","author":"V Nagaraja","year":"2015","unstructured":"Nagaraja V, McMahan ZH, Getzug T, Khanna D. Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol. 2015;1(1):82\u2013105. \n                      https:\/\/doi.org\/10.1007\/s40674-014-0005-0\n                      \n                    .","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"2","key":"841_CR22","doi-asserted-by":"publisher","first-page":"e13247","DOI":"10.1111\/nmo.13247","volume":"30","author":"EK Stern","year":"2018","unstructured":"\u2022 Stern EK, Carlson DA, Falmagne S, Hoffmann AD, Carns M, Pandolfino JE, et al. Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients. Neurogastroenterol Motil. 2018;30(2):e13247. \n                      https:\/\/doi.org\/10.1111\/nmo.13247\n                      \n                    . This study of pH-impedance testing demonstrated that SSc patients had higher and longer acid exposure time, longer median bolus clearance times, and lower noctural impedance values than controls.","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"841_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1572-0241.2005.41210.x","volume":"100","author":"S Charbel","year":"2005","unstructured":"Charbel S, Khandwala F, Vaezi MF. The role of esophageal pH monitoring in symptomatic patients on PPI therapy. Am J Gastroenterol. 2005;100(2):283\u20139. \n                      https:\/\/doi.org\/10.1111\/j.1572-0241.2005.41210.x\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"841_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MPG.0b013e3181ffde67","volume":"52","author":"HM Mousa","year":"2011","unstructured":"Mousa HM, Rosen R, Woodley FW, Orsi M, Armas D, Faure C, et al. Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2011;52(2):129\u201339. \n                      https:\/\/doi.org\/10.1097\/MPG.0b013e3181ffde67\n                      \n                    .","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"841_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/gut.2010.233049","volume":"60","author":"R Farre","year":"2011","unstructured":"Farre R, Blondeau K, Clement D, Vicario M, Cardozo L, Vieth M, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut. 2011;60(7):885\u201392. \n                      https:\/\/doi.org\/10.1136\/gut.2010.233049\n                      \n                    .","journal-title":"Gut."},{"issue":"12","key":"841_CR26","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1038\/ajg.2011.276","volume":"106","author":"BF Kessing","year":"2011","unstructured":"Kessing BF, Bredenoord AJ, Weijenborg PW, Hemmink GJ, Loots CM, Smout AJ. Esophageal acid exposure decreases intraluminal baseline impedance levels. Am J Gastroenterol. 2011;106(12):2093\u20137. \n                      https:\/\/doi.org\/10.1038\/ajg.2011.276\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"841_CR27","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.semarthrit.2017.08.004","volume":"47","author":"P Zentilin","year":"2018","unstructured":"Zentilin P, Savarino V, Marabotto E, Murdaca G, Sulli A, Pizzorni C, et al. Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis. Semin Arthritis Rheum. 2018;47(4):569\u201374. \n                      https:\/\/doi.org\/10.1016\/j.semarthrit.2017.08.004\n                      \n                    .","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"841_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cgh.2013.03.020","volume":"11","author":"F Nicodeme","year":"2013","unstructured":"Nicodeme F, Hirano I, Chen J, Robinson K, Lin Z, Xiao Y, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11(9):1101\u20137 e1. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2013.03.020\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"841_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/nmo.12097","volume":"25","author":"JE Pandolfino","year":"2013","unstructured":"Pandolfino JE, de Ruigh A, Nicodeme F, Xiao Y, Boris L, Kahrilas PJ. Distensibility of the esophagogastric junction assessed with the functional lumen imaging probe (FLIP) in achalasia patients. Neurogastroenterol Motil. 2013;25(6):496\u2013501. \n                      https:\/\/doi.org\/10.1111\/nmo.12097\n                      \n                    .","journal-title":"Neurogastroenterol Motil"},{"issue":"2","key":"841_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1053\/j.gastro.2012.04.048","volume":"143","author":"WO Rohof","year":"2012","unstructured":"Rohof WO, Hirsch DP, Kessing BF, Boeckxstaens GE. Efficacy of treatment for patients with achalasia depends on the distensibility of the esophagogastric junction. Gastroenterology. 2012;143(2):328\u201335. \n                      https:\/\/doi.org\/10.1053\/j.gastro.2012.04.048\n                      \n                    .","journal-title":"Gastroenterology."},{"issue":"8","key":"841_CR31","doi-asserted-by":"publisher","first-page":"e13073","DOI":"10.1111\/nmo.13073","volume":"29","author":"L. Fynne","year":"2017","unstructured":"Fynne L, Liao D, Aksglaede K, Lottrup C, Gregersen H, Bjerregaard NC, et al. Esophagogastric junction in systemic sclerosis: a study with the functional lumen imaging probe. Neurogastroenterol Motil. 2017;29(8). \n                      https:\/\/doi.org\/10.1111\/nmo.13073\n                      \n                    .","journal-title":"Neurogastroenterology & Motility"},{"issue":"2","key":"841_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/nmo.12477","volume":"27","author":"PJ Kahrilas","year":"2015","unstructured":"\u2022\u2022 Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, et al. The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015;27(2):160\u201374. \n                      https:\/\/doi.org\/10.1111\/nmo.12477\n                      \n                    . The version 3.0 of the Chicago classification was developed by the International High Resolution Manometry Group and is an updated analysis scheme for clinical esophageal high resolution manometry recordings.","journal-title":"Neurogastroenterol Motil"},{"issue":"8","key":"841_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1111\/nmo.12813","volume":"28","author":"JN Kimmel","year":"2016","unstructured":"Kimmel JN, Carlson DA, Hinchcliff M, Carns MA, Aren KA, Lee J, et al. The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters. Neurogastroenterol Motil. 2016;28(8):1157\u201365. \n                      https:\/\/doi.org\/10.1111\/nmo.12813\n                      \n                    .","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"841_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/dote\/dox067","volume":"30","author":"N Aggarwal","year":"2017","unstructured":"Aggarwal N, Lopez R, Gabbard S, Wadhwa N, Devaki P, Thota PN. Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification. Dis Esophagus. 2017;30(12):1\u20136. \n                      https:\/\/doi.org\/10.1093\/dote\/dox067\n                      \n                    .","journal-title":"Dis Esophagus"},{"issue":"5","key":"841_CR35","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10067-018-4026-1","volume":"37","author":"S Vettori","year":"2018","unstructured":"\u2022 Vettori S, Tolone S, Capocotta D, Chieffo R, Giacco V, Valentini G, et al. Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value. Clin Rheumatol. 2018;37(5):1239\u201347. \n                      https:\/\/doi.org\/10.1007\/s10067-018-4026-1\n                      \n                    . This study investigated functional esophageal alterations by high-resolution impedance manometry (HRiM) in 45 SSc patients without esophageal symptoms and found that up to 84% of asymptomatic SSc patients have HRiM abnormalities.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"841_CR36","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cgh.2016.03.039","volume":"14","author":"DA Carlson","year":"2016","unstructured":"\u2022 Carlson DA, Crowell MD, Kimmel JN, Patel A, Gyawali CP, Hinchcliff M, et al. Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol. 2016;14(10):1502\u20136. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2016.03.039\n                      \n                    . This retrospective analysis of esophageal peristalsis following multiple rapid swallows in 111 SSc patients showed that impaired peristaltic reserve is the most common manometric finding in SSc patients compared with controls.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"841_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cgh.2016.08.034","volume":"15","author":"MD Crowell","year":"2017","unstructured":"Crowell MD, Umar SB, Griffing WL, DiBaise JK, Lacy BE, Vela MF. Esophageal motor abnormalities in patients with scleroderma: heterogeneity, risk factors, and effects on quality of life. Clin Gastroenterol Hepatol. 2017;15(2):207\u201313 e1. \n                      https:\/\/doi.org\/10.1016\/j.cgh.2016.08.034\n                      \n                    .","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"841_CR38","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1038\/ajg.2013.289","volume":"108","author":"A Shaker","year":"2013","unstructured":"Shaker A, Stoikes N, Drapekin J, Kushnir V, Brunt LM, Gyawali CP. Multiple rapid swallow responses during esophageal high-resolution manometry reflect esophageal body peristaltic reserve. Am J Gastroenterol. 2013;108(11):1706\u201312. \n                      https:\/\/doi.org\/10.1038\/ajg.2013.289\n                      \n                    .","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"841_CR39","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00464-012-2350-0","volume":"26","author":"N Stoikes","year":"2012","unstructured":"Stoikes N, Drapekin J, Kushnir V, Shaker A, Brunt LM, Gyawali CP. The value of multiple rapid swallows during preoperative esophageal manometry before laparoscopic antireflux surgery. Surg Endosc. 2012;26(12):3401\u20137. \n                      https:\/\/doi.org\/10.1007\/s00464-012-2350-0\n                      \n                    .","journal-title":"Surg Endosc"},{"issue":"3","key":"841_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/art.21999","volume":"55","author":"AE Gliddon","year":"2006","unstructured":"Gliddon AE, Dore CJ, Maddison PJ, Quins Trial Study G. Influence of clinical features on the health status of patients with limited cutaneous systemic sclerosis. Arthritis Rheum. 2006;55(3):473\u20139. \n                      https:\/\/doi.org\/10.1002\/art.21999\n                      \n                    .","journal-title":"Arthritis Rheum"},{"issue":"1","key":"841_CR41","first-page":"51","volume":"32","author":"PJ Nietert","year":"2005","unstructured":"Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol. 2005;32(1):51\u20137.","journal-title":"J Rheumatol"},{"issue":"3","key":"841_CR42","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.semarthrit.2017.05.005","volume":"47","author":"HSM Abozaid","year":"2017","unstructured":"Abozaid HSM, Imam HMK, Abdelaziz MM, El-Hammady DH, Fathi NA, Furst DE. High-resolution manometry compared with the University of California, Los Angeles Scleroderma Clinical Trials Consortium GIT 2.0 in systemic sclerosis. Semin Arthritis Rheum. 2017;47(3):403\u20138. \n                      https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.005\n                      \n                    .","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"841_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/MCG.0b013e318167b89d","volume":"43","author":"W Blonski","year":"2009","unstructured":"Blonski W, Vela MF, Freeman J, Sharma N, Castell DO. The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. J Clin Gastroenterol. 2009;43(3):253\u201360. \n                      https:\/\/doi.org\/10.1097\/MCG.0b013e318167b89d\n                      \n                    .","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"841_CR44","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/j.1442-2050.2011.01275.x","volume":"25","author":"M Di Stefano","year":"2012","unstructured":"Di Stefano M, Papathanasopoulos A, Blondeau K, Vos R, Boecxstaens V, Farre R, et al. Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers. Dis Esophagus. 2012;25(5):470\u20136. \n                      https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01275.x\n                      \n                    .","journal-title":"Dis Esophagus"},{"key":"841_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13075-016-1094-y","volume":"18","author":"GP Karamanolis","year":"2016","unstructured":"\u2022 Karamanolis GP, Panopoulos S, Denaxas K, Karlaftis A, Zorbala A, Kamberoglou D, et al. The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial. Arthritis Res Ther. 2016;18:195. \n                      https:\/\/doi.org\/10.1186\/s13075-016-1094-y\n                      \n                    . This study observed that buspirone admnistration improved lower esophageal sphincter resting pressure and esophageal symptoms in most SSc patients with esophageal dysfunction.","journal-title":"Arthritis Res Ther"},{"key":"841_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13075-015-0695-1","volume":"17","author":"JN Taroni","year":"2015","unstructured":"\u2022 Taroni JN, Martyanov V, Huang CC, Mahoney JM, Hirano I, Shetuni B, et al. Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures. Arthritis Res Ther. 2015;17:194. \n                      https:\/\/doi.org\/10.1186\/s13075-015-0695-1\n                      \n                    . This is the first study to characterize the molecular signature of esophageal biopsies from SSc patients.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"841_CR47","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/BOR.0000000000000331","volume":"28","author":"RG Marangoni","year":"2016","unstructured":"Marangoni RG, Varga J, Tourtellotte WG. Animal models of scleroderma: recent progress. Curr Opin Rheumatol. 2016;28(6):561\u201370. \n                      https:\/\/doi.org\/10.1097\/BOR.0000000000000331\n                      \n                    .","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"841_CR48","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.autrev.2018.06.013","volume":"17","author":"X Yue","year":"2018","unstructured":"Yue X, Yu X, Petersen F, Riemekasten G. Recent advances in mouse models for systemic sclerosis. Autoimmun Rev. 2018;17(12):1225\u201334. \n                      https:\/\/doi.org\/10.1016\/j.autrev.2018.06.013\n                      \n                    .","journal-title":"Autoimmun Rev"},{"issue":"4","key":"841_CR49","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1084\/jem.20160247","volume":"214","author":"T Takahashi","year":"2017","unstructured":"\u2022 Takahashi T, Asano Y, Sugawara K, Yamashita T, Nakamura K, Saigusa R, et al. Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma. J Exp Med. 2017;214(4):1129\u201351. \n                      https:\/\/doi.org\/10.1084\/jem.20160247\n                      \n                    . This is the first SSc mouse model reporting an esophageal phenotype.","journal-title":"J Exp Med"},{"key":"841_CR50","doi-asserted-by":"publisher","first-page":"D286","DOI":"10.2741\/A426","volume":"4","author":"SM Karam","year":"1999","unstructured":"Karam SM. Lineage commitment and maturation of epithelial cells in the gut. Front Biosci. 1999;4:D286\u201398.","journal-title":"Front Biosci"},{"issue":"7","key":"841_CR51","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/art.21948","volume":"54","author":"Y Wang","year":"2006","unstructured":"Wang Y, Fan PS, Kahaleh B. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 2006;54(7):2271\u20139. \n                      https:\/\/doi.org\/10.1002\/art.21948\n                      \n                    .","journal-title":"Arthritis Rheum"},{"issue":"3","key":"841_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jdermsci.2010.06.008","volume":"59","author":"Y Asano","year":"2010","unstructured":"Asano Y, Bujor AM, Trojanowska M. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis. J Dermatol Sci. 2010;59(3):153\u201362. \n                      https:\/\/doi.org\/10.1016\/j.jdermsci.2010.06.008\n                      \n                    .","journal-title":"J Dermatol Sci"},{"issue":"9","key":"841_CR53","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1038\/jid.2010.120","volume":"130","author":"N Aden","year":"2010","unstructured":"Aden N, Nuttall A, Shiwen X, de Winter P, Leask A, Black CM, et al. Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol. 2010;130(9):2191\u2013200. \n                      https:\/\/doi.org\/10.1038\/jid.2010.120\n                      \n                    .","journal-title":"J Invest Dermatol"},{"issue":"12","key":"841_CR54","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","volume":"47","author":"N Aden","year":"2008","unstructured":"Aden N, Shiwen X, Aden D, Black C, Nuttall A, Denton CP, et al. Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer. Rheumatology (Oxford). 2008;47(12):1754\u201360. \n                      https:\/\/doi.org\/10.1093\/rheumatology\/ken370\n                      \n                    .","journal-title":"Rheumatology (Oxford)"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-019-0841-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-019-0841-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T23:54:23Z","timestamp":1593647663000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-019-0841-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["841"],"URL":"https:\/\/doi.org\/10.1007\/s11926-019-0841-x","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"3 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"42"}}